# US 2023/0397874 A1 · Cardiac monitoring system with supraventricular tachycardia (svt) classifications

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2023/0397874 A1
- Document ID: US20230397874A1
- Status: Published application
- Kind: A1
- Application number: 18/236,645
- Filed: 2023-08-22
- Published: 2023-12-14
- Earliest claimed: 2019-08-22
- Assignees: West Affum Holdings DAC
- Applicants: West Affum Holdings DAC
- Inventors: Jaeho Kim
- Web page: https://patentgrep.com/patent/US20230397874A1

## CPC

- A61B 5/366: Detecting abnormal QRS complex, e.g. widening
- A61B 5/02405: {Determining heart rate variability}
- A61B 5/282: Holders for multiple electrodes (for introduction into the body A61B5/287)
- A61B 5/35: by template matching
- A61B 5/352: Detecting R peaks, e.g. for synchronising diagnostic apparatus; Estimating R-R interval
- A61B 5/361: Detecting fibrillation
- A61B 5/363: Detecting tachycardia or bradycardia
- A61N 1/046: {Specially adapted for shock therapy, e.g. defibrillation}
- A61N 1/3904: {External heart defibrillators [EHD]}
- A61N 1/395: {for treating atrial fibrillation}
- A61N 1/3956: {Implantable devices for applying electric shocks to the heart, e.g. for cardioversion}
- A61B: DIAGNOSIS; SURGERY; IDENTIFICATION (usefulness limited to only animals A61D)
- A61N: ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY (measurement of bioelectric currents A61B; surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body A61B18/00; anaesthetic apparatus in general A61M; incandescent lamps H01K; infrared radiators for heating H05B)

## Abstract

In one example, a cardiac monitoring system comprises a processor to receive a segment of an electrocardiogram (ECG) signal of a patient, and a memory to store the segment of the ECG. The processor is configured to identify QRS complexes in the segment of the ECG signal, generate a supraventricular (SV) template for SV complexes in the QRS complexes, identify SV complexes in the QRS complexes using the template, identify normal sinus rhythm (NSR) complexes in the segment of the ECG signal, obtain an atrial template for atrial waveforms in the NSR complexes, measure a range of a P-wave of the atrial waveforms from the NSR complexes, save the measured P-waves, and classify the identified SV complexes as either atrial fibrillation (AF) or supraventricular tachycardia (SVT) using the atrial template. Other examples and related methods are also disclosed herein.

## Claims

### Claim at position 1

1-20. (canceled)

### Claim 21

A method to distinguish between atrial fibrillation (AF) and supraventricular tachycardia (SVT) with a cardiac monitoring system comprising electrocardiogram (ECG) electrodes, a processor configured to receive an (ECG) signal of a patient with the ECG electrodes, and a memory to store the ECG signal, the method comprising:
identifying QRS complexes in the ECG signal as supraventricular (SV) complexes by comparing the QRS complexes to an SV template, wherein the QRS complexes are identified as SV complexes when a correlation between the QRS complexes and the SV template is greater than a threshold correlation value;
measuring RR intervals between consecutive pairs of the SV complexes in the received ECG signal to determine RR variability between the SV complexes;
saving atrial waveforms corresponding to the measured RR intervals in a window, wherein the window is sufficiently large to encompass a P-wave and the QRS complex of the SV complexes;
measuring a P-wave range of the P-waves of the saved atrial waveforms; and
classifying the SV complexes as either AF or SVT when the RR variability is greater than a variability threshold;
wherein:
the SV complexes are classified as AF when an amplitude of an atrial template is below a predetermined percentage of the P-wave range; and
the SV complexes are classified as SVT when the amplitude of an atrial template is greater than the predetermined percentage of the P-wave range.

### Claim 22 (depends on 21)

The method of claim 21, wherein:
the SV template is formulated from normally conducted QRS complexes in the ECG signal.

### Claim 23 (depends on 21)

The method of claim 21, wherein:
the atrial template is formulated from normal sinus rhythm (NSR) complexes in the ECG signal.

### Claim 24 (depends on 21)

The method of claim 21, further comprising:
identifying whether a shockable event is detected based at least in part on the classification of the SV complexes; and
applying a defibrillation voltage to the patient when a shockable event is detected.

### Claim 25 (depends on 21)

The method of claim 21, further comprising:
classifying the SV complexes as atrial flutter (AFL) when the RR intervals are integer multiples of a shortest one of the RR intervals.

### Claim 26 (depends on 21)

The method of claim 21, further comprising:
classifying the SV complexes as Wenckebach when the P-waves are similar.

### Claim 27 (depends on 21)

The method of claim 21, further comprising:
determining a heart rate (HR) of the patient based at least in part on the RR intervals; and
classifying the SV complexes AF when the HR is greater than a predetermined heart rate.

### Claim 28 (depends on 21)

The method of claim 21, further comprising:
identifying a first group of the measured RR intervals having highest RR intervals in a threshold range;
wherein atrial waveforms corresponding to the first group of the measured RR intervals are saved.

### Claim 29

A method for cardioverter defibrillator comprising a housing, electrocardiogram (ECG) electrodes, a processor in the housing configured to receive a segment of an ECG signal of a patient with the ECG electrodes, a memory in the housing to store the segment of the ECG signal, and a high voltage subsystem in the housing to apply a defibrillation voltage to the patient, the method comprising:
measuring a P-wave range of the segment of the EGC signal during normal sinus rhythms (NSR);
identifying QRS complexes in the received segment of the ECG signal as supraventricular (SV) complexes by comparing the QRS complexes to an SV template, wherein the QRS complexes are identified as SV complexes when a correlation between the QRS complexes and the SV template is greater than a threshold correlation value;
measuring RR intervals between consecutive pairs of the SV complexes;
determining RR variability from the measured RR intervals between the consecutive pairs of the SV complexes;
formulating a P-wave template of the SV complexes for the measured RR intervals;
classifying the identified SV complexes as either atrial fibrillation (AF) or supraventricular tachycardia (SVT) based at least on part the P-wave template and the RR variability, wherein:
the identified SV complexes are classified as AF when the RR variability is greater than a threshold value and an amplitude of the P-wave template is below a predetermined percentage of the P-wave range; and
the identified SV complexes are classified as SVT when the RR variability is greater than the threshold value and the amplitude of the P-wave template is above the predetermined percentage of the P-wave range; and
applying the defibrillation voltage to the patient when a shockable event is detected based at least in part on the classification of the identified SV complexes.

### Claim 30 (depends on 29)

The method of claim 29, wherein:
the SV template is formulated from normally conducted QRS complexes in the ECG signal.

### Claim 31 (depends on 29)

The method of claim 29, further comprising:
classifying the SV complexes as atrial flutter (AFL) when the RR variability is greater than the threshold value, and the RR intervals are integer multiples of a shortest one of the RR intervals.

### Claim 32 (depends on 29)

The method of claim 29, further comprising:
classifying the SV complexes as Wenckebach when the RR variability is greater than the threshold value, and P-waves in the SV complexes are similar.

### Claim 33 (depends on 29)

The method of claim 29, further comprising:
determining a heart rate (HR) of the patient based at least in part on the RR intervals; and
classifying the SV complexes as SVT when the RR variability is low and the HR is greater than a predetermined heart rate.

### Claim 34

A method for a cardiac monitoring system to distinguish between ventricular tachycardia (VT) and supraventricular tachycardia (SVT) with a cardiac monitoring system comprising electrocardiogram (ECG) electrodes, a processor configured to receive an (ECG) signal of a patient with the ECG electrodes, and a memory to store the ECG signal, the method comprising:
identifying QRS complexes in the ECG signal as supraventricular (SV) complexes by comparing the QRS complexes to an SV template, wherein the QRS complexes are identified as SV complexes when a correlation between the QRS complexes and the SV template is greater than a threshold correlation value;
measuring RR intervals between consecutive pairs of the SV complexes in the received ECG signal to determine RR variability between the SV complexes;
determining a heart rate (HR) of the patient based on the measured RR intervals;
determining when the patient's HR and a QRS width of the QRS complexes is in a VT zone;
saving atrial waveforms corresponding to the measured RR intervals in a window, wherein the window is sufficiently large to encompass a P-wave and the QRS complex of the SV complexes;
measuring a P-wave range of the P-waves of the saved atrial waveforms; and
classifying the QRS complexes as either VT or SVT, wherein:
the QRS complexes are classified as SVT when the RR variability is greater than a variability threshold value and an amplitude of an atrial template is greater than a predetermined percentage of the P-wave range; and
the QRS complexes are otherwise classified as VT when the patient's HR and the QRS width is in the VT zone.

### Claim 35 (depends on 34)

The method of claim 34, wherein:
the SV template is formulated from normally conducted QRS complexes in the ECG signal.

### Claim 36 (depends on 34)

The method of claim 34, wherein:
the atrial template is formulated from normal sinus rhythm (NSR) complexes in the ECG signal.

### Claim 37 (depends on 34)

The method of claim 34, further comprising:
identifying whether a shockable event is detected based at least in part on the classification of the SV complexes; and
applying a defibrillation voltage to the patient when a shockable event is detected.

### Claim 38 (depends on 34)

The method of claim 34, further comprising:
classifying the SV complexes as atrial fibrillation (AF) when the amplitude of the atrial template is below a predetermined percentage of the P-wave range; and
further classifying the SV complexes as atrial flutter (AFL) when the RR variability is greater than the variability threshold value and the RR intervals are integer multiples of a shortest one of the RR intervals.

### Claim 39 (depends on 34)

The method of claim 34, further comprising:
classifying the SV complexes as Wenckebach when the RR variability is greater than the variability threshold value and the P-waves are similar.

### Claim 40 (depends on 34)

The method of claim 34, wherein:
the electrodes are configured to be coupled to be coupled to the patient's skin external to the patient's body.
